Loading resource…

Edward J Benz, Jr, MD, Emanuele Angelucci, MD
The management of thalassemia syndromes can be challenging due to numerous potential disease complications and the limited available therapies, primarily transfusion and hematopoietic cell transplantation. This review covers the management strategies for both alpha and beta thalassemias, including transfusion-dependent and transfusion-independent forms. It also highlights the importance of monitoring and addressing complications associated with the disease, as well as the need for genetic counseling for affected individuals.
No account needed